Clinical application of a new monoclonal antibody (19B7) against PIVKA-II in the diagnosis of hepatocellular carcinoma and pancreatobiliary malignancies

American Journal of Gastroenterology

Volumn 92, Issue 6, 1997, Pages 1031-1034

  Nakao, Akimasa ^a   Taniguchi, Kenji ^a   Inoue, Soichiro ^a   Takeda, Shin ^a   Harada, Akio ^a   Nonami, Toshiaki ^a   Watanabe, Keisuke ^b   Takagi, Hiroshi ^a  

^a NAGOYA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b EISAI CO LTD   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY 19B7; MONOCLONAL ANTIBODY MU 3; PROTHROMBIN; UNCLASSIFIED DRUG;

ANTIBODY AFFINITY; ANTIGEN DETECTION; ARTICLE; BILIARY TRACT CANCER; CONTROLLED STUDY; HUMAN; LIVER CELL CARCINOMA; MAJOR CLINICAL STUDY; PANCREAS CANCER; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL;

ADULT; AGED; AGED, 80 AND OVER; AMPULLA OF VATER; ANTIBODIES, MONOCLONAL; BILE DUCT NEOPLASMS; BILIARY TRACT NEOPLASMS; BIOLOGICAL MARKERS; CARCINOMA; CARCINOMA, HEPATOCELLULAR; COMMON BILE DUCT NEOPLASMS; FEMALE; GALLBLADDER NEOPLASMS; HUMANS; IMMUNOENZYME TECHNIQUES; INCIDENCE; LIVER NEOPLASMS; MALE; MIDDLE AGED; PANCREATIC NEOPLASMS; PROTEIN PRECURSORS; PROTHROMBIN; SENSITIVITY AND SPECIFICITY; TUMOR MARKERS, BIOLOGICAL;

EID: 0030963032     PISSN: 00029270     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (16)

1. Stenflo J, Suttie JW. Vitamin K-dependent formation of γ-carboxyglutamic acid. Ann Rev Biochem 1977;46:157-72.
2. Liebman HA, Furie BC, Tong MJ, et al. Des-γ-carboxy (abnormal) prothrombin as a serum marker of primary hepatocellular carcinoma. N Engl J Med 1984;310:1427-31.
3. Motohara K, Kuroki Y, Kan H, et al. Detection of vitamin K deficiency by use of an enzyme-linked immunosorbent assay for circulating abnormal prothrombin. Pediatr Res 1985;19:354-7.
4. Naraki T, Watanabe K, Shimozuru Y, et al. Development and evaluation of an EIA kit for the detection of PIVKA-II using a two-antibody sandwich system (monoclonal antibody to PIVKA-II and polyclonal antibody to prothrombin). Clin Immunol 1986;18:479-92 (in Japanese).
5. Saitoh S, Ikeda K, Koida I, et al. Serum des-γ-carboxy prothrombin concentration determined by the avidin-biotin complex method in small hepatocellular carcinomas. Cancer 1994;74:2918-23.
6. Nomura F, Ishijima M, Horikoshi A, et al. Determination of serum des-γ-carboxy prothrombin levels in patients with small-sized hepatocellular carcinoma: Comparison of the conventional enzyme immunoassay and two modified methods. Am J Gastroenterol 1996;91: 1380-3.
7. Watanabe K, Naraki T, Iwasaki Y. Purification of PIVKA-II from PLC/PRF/5 cell and production of a new monoclonal antibody. Acta Hepatol Jpn 1994;35:192 (in Japanese).
8. Laurell CB. Quantitative estimation of proteins by electrophoresis in agarose gel containing antibodies. Anal Biochem 1966;15:45-52.
9. Fujiyama S, Morishita T, Sagara K, et al. Clinical evaluation of plasma abnormal prothrombin (PIVKA-II) in patients with hepatocellular carcinoma. Hepatogastroenterology 1986;33:201-5.
10. Okuda H, Obata H, Nakanishi T, et al. Production of abnormal prothrombin (des-γ-carboxy prothrombin) by hepatocellular carcinoma. J Hepatol 1987;4:357-63.
11. Hattori N, Ohmizo R, Unoura M, et al. Abnormal prothrombin measurements in hepatocellular carcinoma. J Tumor Marker Oncol 1988; 3:207-16.
12. Fujiyama S, Morishita T, Hashiguchi O, et al. Plasma abnormal prothrombin (des-γ-carboxy prothrombin) as a marker of hepatocellular carcinoma. Cancer 1988;61:1621-8.
13. Nakao A, Suzuki Y, Isshiki K, et al. Clinical evaluation of plasma abnormal prothrombin (des-γ-carboxy-prothrombin) in hepatobiliary malignancies and other diseases. Am J Gastroenterol 1991;86:62-6.
14. Nakao A, Virji A, Iwaki Y, et al. Abnormal prothrombin (des-γ-carboxy prothrombin) in hepatocellular carcinoma. Hepatogastroenterology 1991;38:450-3.
15. Inoue S, Nakao A, Harada A, et al. Clinical significance of abnormal prothrombin (DCP) in relation to postoperative survival and prognosis in patients with hepatocellular carcinoma. Am J Gastroenterol 1994; 89:2222-6.
16. Sugo I, Watanabe K, Naraki T, et al. Chemical modification of γ-carboxyglutamic acid residues in prothrombin elicits a conformation similar to that of abnormal (des-γ-carboxy) prothrombin. J Biochem 1990;108:382-7.